Company Filing History:
Years Active: 2024
Title: Jan Jos L Bevernage: Innovator in Pharmaceutical Chemistry
Introduction
Jan Jos L Bevernage is a notable inventor based in Kuringen, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical use. His work has led to the creation of a patent that addresses important therapeutic needs.
Latest Patents
Jan Jos L Bevernage holds a patent for "Hemi (L)-tartrate forms of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1-indol-2-yl}methyl)-1-(2,2,2-trifluoroethy)-1,3-dihydro-2-imidazo[4,5-C]pyridin-2-one and pharmaceutical compositions comprising the same." This invention relates to hemi (L)-tartrate forms of the RSV fusion inhibitor, also known as rilematovir. The patent outlines processes for preparing these forms and their use in pharmaceutical compositions, showcasing the potential for significant advancements in treatment options.
Career Highlights
Jan Jos L Bevernage is associated with Janssen Sciences Ireland Unlimited Company, where he continues to contribute to innovative research and development in pharmaceuticals. His expertise in the field has been instrumental in advancing therapeutic solutions.
Collaborations
Jan has collaborated with talented colleagues such as Jasmine Bogaerts and Kristof Leonard Kimpe. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Jan Jos L Bevernage is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable advancements in medical treatments. His contributions, particularly through his patent, highlight the importance of innovation in addressing healthcare challenges.